{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:03:44Z","timestamp":1772780624950,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10157-025-02704-w","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:41:48Z","timestamp":1748356908000},"page":"1583-1590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum matrix metalloproteinase-9 as a predictor of recurrence in idiopathic nephrotic syndrome"],"prefix":"10.1007","volume":"29","author":[{"given":"Masahiko","family":"Ochi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"2704_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1681\/ASN.2012070734","volume":"24","author":"J Hogan","year":"2013","unstructured":"Hogan J, Radhakrishnan J. The treatment of minimal change disease in adults. J Am Soc Nephrol. 2013;24:702\u201311.","journal-title":"J Am Soc Nephrol"},{"key":"2704_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D\u2019Agati V, Appel G. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2:445\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2704_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1681\/ASN.2004070593","volume":"16","author":"S Troyanov","year":"2005","unstructured":"Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol. 2005;16:1061\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"2704_CR4","doi-asserted-by":"crossref","unstructured":"Troyanov S, Jauhal A, Reich HN, Hladunewich MA, Cattran DC, Toronto Glomerulonephritis Registry Group. Focal segmental glomerulosclerosis: assessing the risk of relapse. Kidney Int Rep. 2023;8:2403\u201315.","DOI":"10.1016\/j.ekir.2023.08.035"},{"key":"2704_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2704_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","volume":"31","author":"JC Davin","year":"2016","unstructured":"Davin JC. The glomerular permeability factors in idiopathic nephrotic syndrome. Pediatr Nephrol. 2016;31:207\u201315.","journal-title":"Pediatr Nephrol"},{"key":"2704_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00441-019-03147-y","volume":"379","author":"JJ Candelier","year":"2020","unstructured":"Candelier JJ, Lorenzo HK. Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle. Cell Tissue Res. 2020;379:231\u201343.","journal-title":"Cell Tissue Res"},{"key":"2704_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00467-017-3677-5","volume":"33","author":"M Colucci","year":"2018","unstructured":"Colucci M, Corpetti G, Emma F, Vivarelli M. Immunology of idiopathic nephrotic syndrome. Pediatr Nephrol. 2018;33:573\u201384.","journal-title":"Pediatr Nephrol"},{"key":"2704_CR9","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/ndt\/gfu355","volume":"29","author":"RJ Maas","year":"2014","unstructured":"Maas RJ, Deegens JK, Wetzels JF. Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future. Nephrol Dial Transplant. 2014;29:2207\u201316.","journal-title":"Nephrol Dial Transplant"},{"key":"2704_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011;17:952\u201360.","journal-title":"Nat Med"},{"key":"2704_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1681\/ASN.2021060794","volume":"33","author":"AJB Watts","year":"2022","unstructured":"Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, Waikar SS, Chandraker A, Riella LV, Alexander MP, Troost JP, Chen J, Fermin D, Yee JL, Sampson MG, Beck LH, Henderson JM, Greka A, Rennke HG, Weins A. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol. 2022;33:238\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"2704_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa2314471","volume":"391","author":"FE Hengel","year":"2024","unstructured":"Hengel FE, Dehde S, Lass\u00e9 M, Zahner G, Seifert L, Schnarre A, Kretz O, Demir F, Pinnschmidt HO, Grahammer F, Lucas R, Mehner LM, Zimmermann T, Billing AM, Oh J, Mitrotti A, Pontrelli P, Debiec H, Dossier C, Colucci M, Emma F, Smoyer WE, Weins A, Schaefer F, Alachkar N, Diemert A, Hogan J, Hoxha E, Wiech T, Rinschen MM, Ronco P, Vivarelli M, Gesualdo L, Tomas NM, Huber TB, International Society of Glomerular Disease. Autoantibodies targeting nephrin in Podocytopathies. N Engl J Med. 2024;391:422\u201333.","journal-title":"N Engl J Med"},{"key":"2704_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1042\/BST0350689","volume":"35","author":"E Ganea","year":"2007","unstructured":"Ganea E, Trifan M, Laslo AC, Putina G, Cristescu C. Matrix metalloproteinases: useful and deleterious. Biochem Soc Trans. 2007;35:689\u201391.","journal-title":"Biochem Soc Trans"},{"key":"2704_CR14","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.4049\/jimmunol.158.5.2327","volume":"158","author":"RN Johnatty","year":"1997","unstructured":"Johnatty RN, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam DW, Stephenson TJ, Rees RC. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol. 1997;158:2327\u201333.","journal-title":"J Immunol"},{"key":"2704_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000499876","volume":"44","author":"O Zakiyanov","year":"2019","unstructured":"Zakiyanov O, Kalousov\u00e1 M, Zima T, Tesa\u0159 V. Matrix metalloproteinases in renal diseases: a critical appraisal. Kidney Blood Press Res. 2019;44:298\u2013330.","journal-title":"Kidney Blood Press Res"},{"key":"2704_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1155\/2013\/623196","volume":"34","author":"A Korzeniecka-Kozerska","year":"2013","unstructured":"Korzeniecka-Kozerska A, Wasilewska A, Tenderenda E, Sulik A, Cybulski K. Urinary MMP-9\/NGAL ratio as a potential marker of FSGS in nephrotic children. Dis Markers. 2013;34:357\u201362.","journal-title":"Dis Markers"},{"key":"2704_CR17","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00467-011-1897-7","volume":"26","author":"KA Czech","year":"2011","unstructured":"Czech KA, Bennett M, Devarajan P. Distinct metalloproteinase excretion patterns in focal segmental glomerulosclerosis. Pediatr Nephrol. 2011;26:2179\u201384.","journal-title":"Pediatr Nephrol"},{"key":"2704_CR18","doi-asserted-by":"publisher","first-page":"1620545","DOI":"10.1155\/2021\/1620545","volume":"2021","author":"A Gilbert","year":"2021","unstructured":"Gilbert A, Changjuan A, Guixue C, Jianhua L, Xiaosong Q. Urinary matrix metalloproteinase-9 and nephrin in idiopathic membranous nephropathy: a cross-sectional study. Dis Markers. 2021;2021:1620545.","journal-title":"Dis Markers"},{"key":"2704_CR19","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1681\/ASN.2013030251","volume":"25","author":"P Ruggenenti","year":"2014","unstructured":"Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Maras\u00e0 M, Chianca A, Rubis N, Ene-Iordache B, Rudnicki M, Pollastro RM, Capasso G, Pisani A, Pennesi M, Emma F, Remuzzi G, Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis (NEMO) Study Group. Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol. 2014;25:850\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"2704_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1681\/ASN.2021050643","volume":"33","author":"K Iijima","year":"2022","unstructured":"Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinochi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K, Japanese Study Group of Kidney Disease in Children. Mycophenolate mofetil after rituximab for childhood-onset complicated frequently-relapsing or steroid-dependent nephrotic syndrome. J Am Soc Nephrol. 2022;33:401\u201319.","journal-title":"J Am Soc Nephrol"},{"key":"2704_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10157-014-1022-x","volume":"19","author":"H Yokoyama","year":"2015","unstructured":"Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2015;19:496\u2013505.","journal-title":"Clin Exp Nephrol"},{"key":"2704_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1258\/acb.2009.009007","volume":"46","author":"EJ Lamb","year":"2009","unstructured":"Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009;46:205\u201317.","journal-title":"Ann Clin Biochem"},{"key":"2704_CR23","first-page":"136","volume":"53","author":"S Matsuo","year":"2011","unstructured":"Matsuo S. Guidelines for the treatment of nephrotic syndrome. Jpn J Nephrol. 2011;53:136\u201341.","journal-title":"Jpn J Nephrol"},{"key":"2704_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"2704_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2704_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/CS20150517","volume":"130","author":"H Pulido-Olmo","year":"2016","unstructured":"Pulido-Olmo H, Garc\u00eda-Prieto CF, \u00c1lvarez-Llamas G, Barderas MG, Vivanco F, Aranguez I, Somoza B, Segura J, Kreutz R, Fern\u00e1ndez-Alfonso MS, Ruilope LM, Ruiz-Hurtado G. Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria. Clin Sci (Lond). 2016;130:525\u201338.","journal-title":"Clin Sci (Lond)"},{"key":"2704_CR27","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/ijms18040776","volume":"18","author":"Z Cheng","year":"2017","unstructured":"Cheng Z, Limbu MH, Wang Z, Liu J, Liu L, Zhang X, Chen P, Liu B. MMP-2 and 9 in chronic kidney disease. Int J Mol Sci. 2017;18:776.","journal-title":"Int J Mol Sci"},{"key":"2704_CR28","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/ndt\/15.9.1379","volume":"15","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant. 2000;15:1379\u201383.","journal-title":"Nephrol Dial Transplant"},{"key":"2704_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/ki.2014.67","volume":"86","author":"SY Li","year":"2014","unstructured":"Li SY, Huang PH, Yang AH, Tarng DC, Yang WC, Lin CC, Chen JW, Schmid-Sch\u00f6nbein G, Lin SJ. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation. Kidney Int. 2014;86:358\u201369.","journal-title":"Kidney Int"},{"key":"2704_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123276","volume":"10","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, George J, Li Y, Olufade R, Zhao X. Matrix metalloproteinase-9 expression is enhanced in renal parietal epithelial cells of Zucker diabetic Fatty rats and is induced by albumin in in vitro primary parietal cell culture. PLoS ONE. 2015;10: e0123276.","journal-title":"PLoS ONE"},{"key":"2704_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1681\/ASN.2008050515","volume":"20","author":"S Bengatta","year":"2009","unstructured":"Bengatta S, Arnould C, Letavernier E, Monge M, de Pr\u00e9neuf HM, Werb Z, Ronco P, Lelongt B. MMP9 and SCF protect from apoptosis in acute kidney injury. J Am Soc Nephrol. 2009;20:787\u201397.","journal-title":"J Am Soc Nephrol"},{"key":"2704_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3892\/etm.2013.1409","volume":"7","author":"L Wang","year":"2014","unstructured":"Wang L, Wang J, Wang Y, Fu Q, Lei YH, Nie ZY, Qiu J, Bao TY. Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure. Exp Ther Med. 2014;7:329\u201334.","journal-title":"Exp Ther Med"},{"key":"2704_CR33","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1093\/ndt\/gfh186","volume":"19","author":"JSF Sanders","year":"2004","unstructured":"Sanders JSF, van Goor H, Hanemaaijer R, Kallenberg CGM, Stegeman CA. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2004;19:1412\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"2704_CR34","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/ndt\/17.7.1189","volume":"17","author":"M Urushihara","year":"2002","unstructured":"Urushihara M, Kagami S, Kuhara T, Tamaki T, Kuroda Y. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis. Nephrol Dial Transplant. 2002;17:1189\u201396.","journal-title":"Nephrol Dial Transplant"},{"key":"2704_CR35","doi-asserted-by":"publisher","first-page":"F1927","DOI":"10.1152\/ajprenal.00310.2007","volume":"293","author":"JSF Sanders","year":"2007","unstructured":"Sanders JSF, Huitema MG, Hanemaaijer R, van Goor H, Kallenberg CGM, Stegeman CA. Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis. Am J Physiol Ren Physiol. 2007;293:F1927\u201334.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2704_CR36","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1172\/JCI118502","volume":"97","author":"JI McMillan","year":"1996","unstructured":"McMillan JI, Riordan JW, Couser WG, Pollock AS, Lovett DH. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest. 1996;97:1094\u2013101.","journal-title":"J Clin Invest"},{"key":"2704_CR37","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/ndt\/gfl743","volume":"22","author":"B Bauvois","year":"2007","unstructured":"Bauvois B, Mothu N, Nguyen J, Nguyen-Khoa T, N\u00f6el LH, Jungers P. Specific changes in plasma concentrations of matrix metalloproteinase-2 and \u22129, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis. Nephrol Dial Transplant. 2007;22:1115\u201322.","journal-title":"Nephrol Dial Transplant"},{"key":"2704_CR38","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00296-014-3112-1","volume":"35","author":"PA Klimiuk","year":"2015","unstructured":"Klimiuk PA, Domys\u0142awska I, Sierakowski S, Chwie\u0107ko J. Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockers. Rheumatol Int. 2015;35:749\u201355.","journal-title":"Rheumatol Int"},{"key":"2704_CR39","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1002\/art.30615","volume":"63","author":"PA Monach","year":"2011","unstructured":"Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CGM, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Gu YZ, Snyder RD, Merkel PA. Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2011;63:3988\u201397.","journal-title":"Arthritis Rheum"},{"key":"2704_CR40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1681\/ASN.2006060568","volume":"2","author":"A Doller","year":"2007","unstructured":"Doller A, Akool e-S, M\u00fcller R, Gutwein P, Kurowski C, Pfeilschifter J, Eberhardt W. Molecular mechanisms of cyclosporin A inhibition of the cytokine-induced matrix metalloproteinase-9 in glomerular mesangial cells. J Am Soc Nephrol. 2007;2:581\u201392.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2704_CR41","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.bbrc.2018.07.014","volume":"503","author":"CE Francis","year":"2018","unstructured":"Francis CE, Bai Y. Differential expression of cyclosporine A-Induced calcineurin isoform-specific matrix metalloproteinase 9 (MMP-9) in renal fibroblasts. Biochem Biophys Res Commun. 2018;503(4):2549\u201354.","journal-title":"Biochem Biophys Res Commun"},{"key":"2704_CR42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","volume":"83","author":"CS De Paiva","year":"2006","unstructured":"De Paiva CS, Corrales RM, Villarreal AL, Farley WJ, Li DQ, Stern ME, Pflugfelder SC. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res. 2006;83:526\u201335.","journal-title":"Exp Eye Res"},{"issue":"3","key":"2704_CR43","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/lary.21462","volume":"121","author":"O Yigit","year":"2011","unstructured":"Yigit O, Acio\u011flu E, Geli\u015fgen R, Server EA, Azizli E, Uzun H. The effect of corticosteroid on metalloproteinase levels of nasal polyposis. Laryngoscope. 2011;121(3):667\u201373.","journal-title":"Laryngoscope"},{"key":"2704_CR44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12070-013-0656-4","volume":"65","author":"H Cincik","year":"2013","unstructured":"Cincik H, Erkul E, Pinar D, Ipcioglu O, Gungor A, Cekin E, Cakmak A. Evaluation of MMP-9 and TIMP-1 levels of the patients with nasal polyposis after corticosteroid therapies. Indian J Otolaryngol Head Neck Surg. 2013;65:445\u20139.","journal-title":"Indian J Otolaryngol Head Neck Surg"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02704-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:03:18Z","timestamp":1761714198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02704-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02704-w","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were as per the ethical standards of the Medical Ethics Committee of Kanazawa University (Approval number 2,410) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}